Genetic Variations in the Flanking Regions of miR-101-2 Are Associated with Increased Risk of Breast Cancer

• Jiaping Chen,

  Affiliations MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯
• Zhenzhen Qin,

  Affiliation State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China

  ⨯
• Yue Jiang,

  Affiliations MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China, State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China

  ⨯
• Yanru Wang,

  Affiliation Department of Medical Oncology, Jinling Hospital, Southern Medical University, Nanjing, China

  ⨯
• Yisha He,

  Affiliation State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China

  ⨯
• Juncheng Dai,

  Affiliation MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China

  ⨯
• Guangfu Jin,

  Affiliations MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China, State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯
• Hongxia Ma,

  Affiliations MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China, State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯
• Zhibin Hu,

  Affiliations MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China, State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯
• Yongmei Yin ,

  * E-mail: ym.yin@hotmail.com (YY); hbshen@njmu.edu.cn (HS)

  Affiliation Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  ⨯
• Hongbing Shen

  * E-mail: ym.yin@hotmail.com (YY); hbshen@njmu.edu.cn (HS)

  Affiliations MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China, State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯